Gross Margin - Fujian Cosunter Pharmaceutical Co Ltd (SZSE:300436) - Alpha Spread
F

Fujian Cosunter Pharmaceutical Co Ltd
SZSE:300436

Watchlist Manager
Fujian Cosunter Pharmaceutical Co Ltd
SZSE:300436
Watchlist
Price: 18.43 CNY -1.34% Market Closed
Market Cap: 2.9B CNY
Have any thoughts about
Fujian Cosunter Pharmaceutical Co Ltd?
Write Note

Gross Margin
Fujian Cosunter Pharmaceutical Co Ltd

56%
Current
59%
Average
48.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
56%
=
Gross Profit
254.3m
/
Revenue
454.5m

Gross Margin Across Competitors

Country CN
Market Cap 2.9B CNY
Gross Margin
56%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 879.6B USD
Gross Margin
81%
Country DK
Market Cap 4.1T DKK
Gross Margin
85%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country US
Market Cap 400.6B USD
Gross Margin
69%
Country US
Market Cap 299.1B USD
Gross Margin
76%
Country CH
Market Cap 211.2B CHF
Gross Margin
73%
Country UK
Market Cap 245.9B USD
Gross Margin
82%
Country CH
Market Cap 192.9B CHF
Gross Margin
75%
Country US
Market Cap 169B USD
Gross Margin
71%

Profitability Report

View the profitability report to see the full profitability analysis for Fujian Cosunter Pharmaceutical Co Ltd.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
56%
=
Gross Profit
254.3m
/
Revenue
454.5m
What is the Gross Margin of Fujian Cosunter Pharmaceutical Co Ltd?

Based on Fujian Cosunter Pharmaceutical Co Ltd's most recent financial statements, the company has Gross Margin of 56%.